Disposable Heart Pulse Field Ablation Catheter Approved for Market Launch
In March 2024, the National Medical Products Administration approved the registration application for the innovative product "Disposable Heart Pulse Field Ablation Catheter" from Hangzhou Dinova.
The product, consisting of a catheter and connecting cables, is designed to be used in conjunction with the company's heart pulse field ablation instrument. By controlling and releasing pulse field energy of appropriate intensity, it selectively induces irreversible electrical perforation damage only to the myocardial cells at the site requiring treatment, thereby achieving the goal of treating atrial fibrillation. This product provides more treatment options for drug-resistant, recurrent, symptomatic, and paroxysmal atrial fibrillation.
The drug regulatory authorities will strengthen supervision of the product after its market launch to ensure patient safety.
For inquiries, contact TX Medical at.